drugset / Trial / NCT00739440

Randomized Controlled Trial to Compare Two Anti-scorpion Serums

NCT00739440

Phase 4 Completed 120 enrolled Birmex
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Timeline

Start
2008-08
Primary completion
2008-10
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Antiscorpion venom serum Protein / enzyme biologic

Indications